澳大利亚和新西兰每年诊断出约 16,000 例新肺癌病例，是该地区癌症死亡的主要原因。尽管尚未建立促进整个澳大利亚基准的临床质量指标，但多年来肺癌治疗和结果的无根据变化一直被描述。本研究的目的是建立适用于澳大利亚和新西兰的肺癌和其他胸部癌症的临床质量指标。经过文献综述后，在 2022 年 10 月至 2023 年 6 月期间完成了修改后的三轮 eDelphi 共识流程。参与者包括来自以下国家的临床医生所有相关学科、患者权益倡导者、研究人员和其他利益相关者，以及来自澳大利亚所有州和地区以及新西兰的代表。共识门槛设定为70%，前两轮以在线调查方式进行，最后一轮以面对面和虚拟共识会议相结合的方式举行。文献综述确定了422项国际胸部肿瘤学指标，共计71项指标在德尔菲共识过程中进行了评估。最终，27项临床质量指标达成共识，涵盖胸部肿瘤护理从诊断到一线治疗的连续过程。支持性护理的基准指标没有得到充分体现。制定了相应的数字质量标准以促进基准测试。制定了与澳大利亚胸部肿瘤护理相关的二十七个临床质量指标。现在将利用在澳大利亚收集的前瞻性数据集来探索现实世界的实施。© 2024 作者。约翰·威利出版的《呼吸学》

Approximately 16,000 new cases of lung cancer are diagnosed each year in Australia and Aotearoa New Zealand, and it is the leading cause of cancer death in the region. Unwarranted variation in lung cancer care and outcomes has been described for many years, although clinical quality indicators to facilitate benchmarking across Australasia have not been established. The purpose of this study was to establish clinical quality indicators applicable to lung and other thoracic cancers across Australia and Aotearoa New Zealand.Following a literature review, a modified three round eDelphi consensus process was completed between October 2022 and June 2023. Participants included clinicians from all relevant disciplines, patient advocates, researchers and other stakeholders, with representatives from all Australian states and territories and Aotearoa New Zealand. Consensus was set at a threshold of 70%, with the first two rounds conducted as online surveys, and the final round held as a hybrid in person and virtual consensus meeting.The literature review identified 422 international thoracic oncology indicators, and a total of 71 indicators were evaluated over the course of the Delphi consensus. Ultimately, 27 clinical quality indicators reached consensus, covering the continuum of thoracic oncologic care from diagnosis to first line treatment. Indicators benchmarking supportive care were poorly represented. Attendant numeric quality standards were developed to facilitate benchmarking.Twenty-seven clinical quality indicators relevant to thoracic oncology care in Australasia were developed. Real world implementation will now be explored utilizing a prospective dataset collected across Australia.© 2024 The Author(s). Respirology published by John Wiley & Sons Australia, Ltd on behalf of Asian Pacific Society of Respirology.